These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9674796)

  • 1. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.
    Heyman A; Fillenbaum GG; Welsh-Bohmer KA; Gearing M; Mirra SS; Mohs RC; Peterson BL; Pieper CF
    Neurology; 1998 Jul; 51(1):159-62. PubMed ID: 9674796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
    Snowdon DA; Greiner LH; Mortimer JA; Riley KP; Greiner PA; Markesbery WR
    JAMA; 1997 Mar; 277(10):813-7. PubMed ID: 9052711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease.
    Lee JH; Olichney JM; Hansen LA; Hofstetter CR; Thal LJ
    Arch Neurol; 2000 Oct; 57(10):1474-9. PubMed ID: 11030800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.
    Honig LS; Kukull W; Mayeux R
    Neurology; 2005 Feb; 64(3):494-500. PubMed ID: 15699381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
    Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
    J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.
    Heyman A; Fillenbaum GG; Gearing M; Mirra SS; Welsh-Bohmer KA; Peterson B; Pieper C
    Neurology; 1999 Jun; 52(9):1839-44. PubMed ID: 10371532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological assessment of Alzheimer's disease: the experience of the Consortium to Establish a Registry for Alzheimer's Disease.
    Mirra SS
    Int Psychogeriatr; 1997; 9 Suppl 1():263-8; discussion 269-72. PubMed ID: 9447447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease with and without cerebral infarcts.
    Del Ser T; Hachinski V; Merskey H; Munoz DG
    J Neurol Sci; 2005 Apr; 231(1-2):3-11. PubMed ID: 15792814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
    Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
    Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.
    Hulette C; Mirra S; Wilkinson W; Heyman A; Fillenbaum G; Clark C
    Neurology; 1995 Nov; 45(11):1991-5. PubMed ID: 7501147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    Nerg O; Junkkari A; Hallikainen I; Rauramaa T; Luikku A; Hiltunen M; Jääskeläinen JE; Leinonen V; Hänninen T; Koivisto A
    J Alzheimers Dis; 2021; 81(3):1117-1130. PubMed ID: 33896842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
    Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
    J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Mirra SS; Heyman A; McKeel D; Sumi SM; Crain BJ; Brownlee LM; Vogel FS; Hughes JP; van Belle G; Berg L
    Neurology; 1991 Apr; 41(4):479-86. PubMed ID: 2011243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.
    Rossetti HC; Munro Cullum C; Hynan LS; Lacritz LH
    Alzheimer Dis Assoc Disord; 2010; 24(2):138-42. PubMed ID: 20505431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.